Kadimastem Stock Net Income
| KMSTF Stock | USD 2.47 0.20 8.81% |
As of the 14th of February 2026, Kadimastem secures the Mean Deviation of 5.28, standard deviation of 7.93, and Risk Adjusted Performance of (0.12). Kadimastem technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kadimastem mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Kadimastem is priced some-what accurately, providing market reflects its recent price of 2.47 per share. Please also check out Kadimastem jensen alpha, which is currently at (1.22) to check the company can sustain itself at a future point.
Kadimastem's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Kadimastem's valuation are provided below:Kadimastem does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Kadimastem |
Search Suggestions
| K | Kellanova | CompanyDelisted |
| KEY-PI | KeyCorp | Company |
| KB | KB Financial Group | Company |
| KF | Korea Closed | Fund |
| KAT | Scharf ETF | ETF |
| KSM | KSM | Cryptocurrency |
| KCUSX | Coffee | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Kadimastem reported net income of (26.27 Million). This is 107.7% lower than that of the Healthcare sector and 137.51% lower than that of the Biotechnology industry. The net income for all United States stocks is 104.6% higher than that of the company.
Kadimastem Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kadimastem's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kadimastem could also be used in its relative valuation, which is a method of valuing Kadimastem by comparing valuation metrics of similar companies.Kadimastem is currently under evaluation in net income category among its peers.
Kadimastem Fundamentals
| Return On Equity | -7.35 | |||
| Return On Asset | -0.75 | |||
| Current Valuation | 10.09 M | |||
| Shares Outstanding | 35.76 M | |||
| Shares Owned By Insiders | 53.72 % | |||
| Shares Owned By Institutions | 8.31 % | |||
| Price To Book | 5.03 X | |||
| EBITDA | (24.48 M) | |||
| Net Income | (26.27 M) | |||
| Cash And Equivalents | 250 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 9.31 M | |||
| Debt To Equity | 0.39 % | |||
| Current Ratio | 2.14 X | |||
| Cash Flow From Operations | (21.55 M) | |||
| Beta | 0.69 | |||
| Market Capitalization | 23.24 M | |||
| Total Asset | 27.34 M | |||
| Z Score | 1.2 | |||
| Net Asset | 27.34 M |
About Kadimastem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kadimastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kadimastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kadimastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Kadimastem Pink Sheet
Kadimastem financial ratios help investors to determine whether Kadimastem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kadimastem with respect to the benefits of owning Kadimastem security.